Stimulation programs for pediatric drug research – do children really benefit?

Most drugs that are currently prescribed in pediatrics have not been tested in children. Pediatric drug studies are stimulated in the USA by the pediatric exclusivity provision under the Food and Drug Administration Modernization Act (FDAMA) that grants patent extensions when pediatric labeling is p...

Descripción completa

Detalles Bibliográficos
Autores principales: Boots, Isabelle, Sukhai, Rám N., Klein, Richard H., Holl, Robert A., Wit, Jan M., Cohen, Adam F., Burggraaf, Jacobus
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2007
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1914295/
https://www.ncbi.nlm.nih.gov/pubmed/17225950
http://dx.doi.org/10.1007/s00431-006-0381-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1914295/
https://www.ncbi.nlm.nih.gov/pubmed/17225950
http://dx.doi.org/10.1007/s00431-006-0381-z

Ejemplares similares